Sofinnova Partners
Matthieu Coutet currently serves as a Partner at Sofinnova Partners, having joined the firm in August 2023. Prior to this role, Matthieu Coutet held several positions as a board member, including at Integra Therapeutics from December 2021 to July 2023, Ribonexus from July 2021 to July 2023, DiogenX from May 2020 to July 2023, and YUKIN Therapeutics from September 2018 to July 2023. Matthieu Coutet obtained a Master's degree in Engineering/Industrial Management from ESIEE Paris, where studies were completed between January 2002 and January 2005.
This person is not in any teams
This person is not in any offices